RORγt inverse agonist 28
RORγt inverse agonist 28 is a potent reverse agonist of RORγt. RORγt inverse agonist 28 regulates the differentiation of Th17 cells and inhibits the production of IL-17. RORγt inverse agonist 28 has the potential for the research of inflammation and autoimmune diseases (extracted from patent WO2021228215A1, compound 6) [1].
Product Specifications
CAS Number
2741870-21-1
UNSPSC
12352005
Target
ROR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/rorγt-inverse-agonist-28.html
Solubility
10 mM in DMSO
Smiles
FC(F)(F)OC1=C(C2=C(C=C(C=C2Cl)NC([C@H](C3=CC=C(C=C3)S(C)(=O)=O)CO)=O)Cl)C=CC=C1
Molecular Formula
C23H18Cl2F3NO5S
Molecular Weight
548.36
References & Citations
[1]Yaobang Chen, et al. Biaryls as RORγ Modulators. Patent WO2021228215A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PTGES2 (Prostaglandin E Synthase 2, GBF1, GBF-1, PGES2, C9orf15, mPGES-2) (FITC)
PTGES2 (Prostaglandin E Synthase 2, GBF1, GBF-1, PGES2, C9orf15, mPGES-2) (FITC)
Lentiviral mouse Tmem74 shRNA (UAS) - Lentiviral mouse Tmem74 shRNA (UAS, iRFP) plasmid
Human Block Of Proliferation 1 (BOP1) ELISA Kit